Skip to content
  • Home
  • Portfolio
  • Investment
  • News
  • Team
  • Contact
  • Utrecht Holdings
  • Home
  • Portfolio
  • Investment
  • News
  • Team
  • Contact
  • Utrecht Holdings

Month: August 2023

Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies

A very warm welcome to new portfolio company Phlox Therapeutics, a private biotechnology company specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies.

The Utrecht Holdings Seed Fund invests in science-based startups in: Life Sciences / MedTech, Digital Innovation and Sustainability. It is managed by Utrecht Holdings.

Menu

  • Home
  • Portfolio
  • Investment
  • News
  • Team
  • Contact
  • Utrecht Holdings
  • Home
  • Portfolio
  • Investment
  • News
  • Team
  • Contact
  • Utrecht Holdings

Visiting address

Utrecht Holdings
Heidelberglaan 8
Room 0.43
3584 CS Utrecht
The Netherlands

Contact Us

contact@uhsf.nl

T: 085 – 087 63 69

Linkedin

Contact Us

contact@uhsf.nl

T: 085 – 087 63 69

Linkedin

BTW-nummers (VAT numbers): UU Holding BV: NL806771604B01  ||  UMCU Holding BV: NL806125214B01